RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Argent Biopharma Stock

Argent Biopharma ROA 2025

Argent Biopharma ROA

-1.63

Ticker

RGT.AX

ISIN

AU0000326647

WKN

A2ACB6

In 2025, Argent Biopharma's return on assets (ROA) was -1.63, a -22.09% increase from the -2.09 ROA in the previous year.

Argent Biopharma Aktienanalyse

What does Argent Biopharma do?

Argent Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Argent Biopharma's Return on Assets (ROA)

Argent Biopharma's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Argent Biopharma's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Argent Biopharma's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Argent Biopharma’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Argent Biopharma stock

What is the Return on Assets (ROA) of Argent Biopharma this year?

The Return on Assets (ROA) of Argent Biopharma is -1.63 undefined this year.

What was the ROA of Argent Biopharma compared to the previous year?

The ROA of Argent Biopharma has increased by -22.09% compared to the previous year.

What consequences do high ROA have for investors of Argent Biopharma?

A high ROA is advantageous for investors of Argent Biopharma, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Argent Biopharma?

A low ROA can be unfavorable for investors of Argent Biopharma as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Argent Biopharma affect the company?

An increase in ROA of Argent Biopharma can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Argent Biopharma impact the company?

A reduction in the ROA of Argent Biopharma can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Argent Biopharma?

Some factors that can influence the ROA of Argent Biopharma include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Argent Biopharma important for investors?

The ROA of Argent Biopharma is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Argent Biopharma take to improve ROA?

To improve ROA, Argent Biopharma can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Argent Biopharma pay?

Over the past 12 months, Argent Biopharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Argent Biopharma is expected to pay a dividend of 0 AUD.

What is the dividend yield of Argent Biopharma?

The current dividend yield of Argent Biopharma is .

When does Argent Biopharma pay dividends?

Argent Biopharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Argent Biopharma?

Argent Biopharma paid dividends every year for the past 0 years.

What is the dividend of Argent Biopharma?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Argent Biopharma located?

Argent Biopharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Argent Biopharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Argent Biopharma from 1/15/2025 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 1/15/2025.

When did Argent Biopharma pay the last dividend?

The last dividend was paid out on 1/15/2025.

What was the dividend of Argent Biopharma in the year 2024?

In the year 2024, Argent Biopharma distributed 0 AUD as dividends.

In which currency does Argent Biopharma pay out the dividend?

The dividends of Argent Biopharma are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Argent Biopharma

Our stock analysis for Argent Biopharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Argent Biopharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.